Format
Sort by

Send to

Choose Destination

Search results

Items: 18

1.

Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study.

Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.

PLoS Med. 2016 Sep 20;13(9):e1002128. doi: 10.1371/journal.pmed.1002128.

2.

Reduction in sodium intake is independently associated with improved blood pressure control in people with chronic kidney disease in primary care.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, Shardlow A, McIntyre CW, Taal MW.

Br J Nutr. 2015 Sep 28;114(6):936-42. doi: 10.1017/S0007114515002494.

PMID:
26243465
3.

Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Taal MW.

Nephron Clin Pract. 2014;128(1-2):61-6. doi: 10.1159/000363297.

PMID:
25342580
4.

High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Taal MW.

Eur J Clin Nutr. 2015 Jul;69(7):786-90. doi: 10.1038/ejcn.2014.215.

PMID:
25293433
5.

Skin autofluorescence and all-cause mortality in stage 3 CKD.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1361-8. doi: 10.2215/CJN.09510913.

6.

Assessment of proteinuria in patients with chronic kidney disease stage 3: albuminuria and non-albumin proteinuria.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre C, Fluck R, Taal MW.

PLoS One. 2014 May 27;9(5):e98261. doi: 10.1371/journal.pone.0098261.

7.

Demographic associations of high estimated sodium intake and frequency of consumption of high-sodium foods in people with chronic kidney disease stage 3 in England.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Willingham FC, Taal MW.

J Ren Nutr. 2014 Jul;24(4):236-42. doi: 10.1053/j.jrn.2014.03.003.

PMID:
24788310
8.

The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.

Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW.

Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537.

PMID:
24429404
9.

Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

BMC Fam Pract. 2013 Jun 24;14:88. doi: 10.1186/1471-2296-14-88.

10.

Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.

Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.

Nephron Clin Pract. 2012;122(1-2):58-65. doi: 10.1159/000348835.

PMID:
23548499
11.

Determinants of arterial stiffness in chronic kidney disease stage 3.

McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW.

PLoS One. 2013;8(1):e55444. doi: 10.1371/journal.pone.0055444.

12.

Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease.

McIntyre NJ, Fluck R, McIntyre C, Taal M.

Br J Gen Pract. 2012 Apr;62(597):e227-32. doi: 10.3399/bjgp12X636047.

13.

Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3.

Evans PD, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.

PLoS One. 2012;7(4):e34699. doi: 10.1371/journal.pone.0034699.

14.

Risk profile in chronic kidney disease stage 3: older versus younger patients.

McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.

Nephron Clin Pract. 2011;119(4):c269-76. doi: 10.1159/000329109.

PMID:
21921639
15.

Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.

McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2356-63. doi: 10.2215/CJN.02420311.

16.

Tissue-advanced glycation end product concentration in dialysis patients.

McIntyre NJ, Chesterton LJ, John SG, Jefferies HJ, Burton JO, Taal MW, Fluck RJ, McIntyre CW.

Clin J Am Soc Nephrol. 2010 Jan;5(1):51-5. doi: 10.2215/CJN.05350709.

17.

How to measure proteinuria?

McIntyre NJ, Taal MW.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):600-3. doi: 10.1097/MNH.0b013e328313675c. Review.

PMID:
18941353
18.

The mini-mental state examination: a comprehensive review.

Tombaugh TN, McIntyre NJ.

J Am Geriatr Soc. 1992 Sep;40(9):922-35. Review.

PMID:
1512391
Items per page

Supplemental Content

Loading ...
Support Center